Computer‐assisted analysis of molecular mimicry between human papillomavirus 16 E7 oncoprotein and human protein sequences
暂无分享,去创建一个
Alberta Lucchese | Darja Kanduc | D. Kanduc | Costanzo Natale | Costanzo Natale | T. Giannini | A. Lucchese | Teresa Giannini
[1] V. Schirrmacher,et al. Modification of tumor cells by a low dose of Newcastle Disease Virus. , 1988, European journal of immunology.
[2] H. Moch,et al. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms. , 1998, Anticancer research.
[3] R. Lerner,et al. Antibodies that react with predetermined sites on proteins. , 1983, Science.
[4] I. Auger,et al. Molecular mimicry reflected through database screening: serendipity or survival strategy? , 1996, Immunology today.
[5] Alphonse García,et al. Protein phosphatase 2A is a critical regulator of protein kinase C ζ signaling targeted by SV40 small t to promote cell growth and NF‐κB activation , 1997 .
[6] S. Suhai,et al. Human papillomavirus type 16 DNA sequence. , 1985, Virology.
[7] G. Tortolero-Luna,et al. Studies on in vivo induction of cytotoxic T lymphocyte responses by synthetic peptides from E6 and E7 oncoproteins of human papillomavirus type 16. , 1995, Viral immunology.
[8] Terri K. Attwood,et al. The PRINTS protein fingerprint database in its fifth year , 1998, Nucleic Acids Res..
[9] S. Papa,et al. Cell Growth and Oncogenesis , 1998, Molecular and Cell Biology Updates.
[10] M Peakman,et al. Molecular mimicry in the MHC: hidden clues to autoimmunity? , 1996, Immunology today.
[11] H. zur Hausen,et al. Papillomavirus infections--a major cause of human cancers. , 1996, Biochimica et biophysica acta.
[12] Hans-Werner Mewes,et al. The PIR-International Protein Sequence Database , 1992, Nucleic Acids Res..
[13] H. Rammensee,et al. SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.
[14] A. Garcia,et al. Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation. , 1997, The EMBO journal.
[15] F. Marincola,et al. Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] I. Frazer,et al. A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. McMillan,et al. The ability of peptides to induce cytotoxic T cells in vitro does not strongly correlate with their affinity for the H-2Ld molecule: implications for vaccine design and immunotherapy. , 1997, Molecular immunology.
[18] C. Lacey,et al. Toward a human papillomavirus vaccine. , 1998, Dermatologic clinics.
[19] M. Tommasino,et al. E7 protein of human papillomaviruses and its interaction with cellular pathways , 1998 .
[20] M. Feltkamp,et al. Efficient MHC class I-peptide binding is required but does not ensure MHC class I-restricted immunogenicity. , 1994, Molecular immunology.
[21] H. Fleury,et al. [Serological study of the virus responsible for hemorrhagic fever in an urban population of Cameroon]. , 1988, Bulletin de la Societe de pathologie exotique et de ses filiales.
[22] Cathy H. Wu,et al. The PIR-International Protein Sequence Database , 1999, Nucleic Acids Res..
[23] I. Frazer,et al. Immunology of papillomavirus infection. , 1996, Current opinion in immunology.
[24] Rolf Apweiler,et al. The SWISS-PROT protein sequence data bank and its new supplement TREMBL , 1996, Nucleic Acids Res..
[25] D. Pardoll,et al. Antigen‐specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein , 1998, International journal of cancer.
[26] M. Oldstone. Molecular mimicry and immune‐mediated diseases , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] P. Bonnier,et al. c-myc protein and Ki-67 antigen immunodetection in patients with uterine cervix neoplasia: correlation of microcytophotometric analysis and histological data. , 1993, Gynecologic oncology.
[28] M. von Knebel Doeberitz,et al. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions , 1994, Journal of virology.
[29] R. Rossen,et al. Antibody development to viral and allogeneic tumor cell-associated antigens in patients with malignant melanoma and ovarian carcinoma treated with lysates of virus-infected tumor cells. , 1986, Cancer research.
[30] R. Wood,et al. Identical defects in DNA repair in xeroderma pigmentosum group G and rodent ERCC group 5 , 1993, Nature.
[31] M. Feltkamp,et al. Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells , 1993, European journal of immunology.